Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
OCULAR THERAPEUTIX, INC (OCUL) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Investor presentation
Docs: "Ocular Therapeutix, Inc. slide presentation"
10/03/2023 8-K Other Events  Interactive Data
08/07/2023 8-K Quarterly results
Docs: "Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update"
07/12/2023 8-K Quarterly results
07/07/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "Agreements"
06/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/12/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "0 4 8 12 16 20 24 28 32 36 40 44 48 52"
05/08/2023 8-K Quarterly results
Docs: "EXHIBI 99.1"
04/06/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
03/06/2023 8-K Quarterly results
Docs: "Ocular Therapeutix™ Provides Fourth Quarter and Year-End 2022 Results and Corporate Update"
01/06/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Ocular Therapeutix™ Provides 2022 Year End Corporate Update and Reviews Expected 2023 Milestones"
11/07/2022 8-K Quarterly results
Docs: "Ocular Therapeutix™ Reports Third Quarter 2022 Financial Results and Business Update"
09/29/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
06/08/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
Docs: "Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Update"
02/28/2022 8-K Quarterly results
02/07/2022 8-K Quarterly results
11/08/2021 8-K Quarterly results
Docs: "Ocular Therapeutix™ Reports Third Quarter 2021 Financial Results and Business Update"
09/22/2021 8-K Quarterly results
08/09/2021 8-K Quarterly results
08/09/2021 8-K Quarterly results
Docs: "Ocular Therapeutix™ Reports Second Quarter 2021 Financial Results and Business Update"
07/22/2021 8-K Quarterly results
06/22/2021 8-K Quarterly results
06/04/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
04/29/2021 8-K Quarterly results
04/27/2021 8-K Quarterly results
03/11/2021 8-K Quarterly results
02/12/2021 8-K Quarterly results
01/20/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BASED TRAVOPROST IMPLANT TO TREAT PATIENTS WITH GLAUCOMA"
01/08/2021 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM"
12/18/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNDERWRITING AGREEMENT",
"Letter re: Prospectus Supplement to Registration Statement on Form S-3",
"Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock",
"Ocular Therapeutix TM Announces Pricing of Public Offering of Common Stock BEDFORD, Mass, December 15, 2020 - Ocular Therapeutix™, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the pricing of an underwritten public offering of 3,725,000 shares of its common stock at a public offering price of $21.50 per share for gross proceeds of approximately $80.1 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. In addition, the Company has granted the underwriters of the offering a 30-day option to purchase up to an additional 558,750 shares in the public offering on the same terms and conditions. Al..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy